Alan Schmaljohn, PhD, is a Professor of Microbiology and Immunology at the University of Maryland School of Medicine. He is an expert in vaccines and treatments for deadly viruses, including Ebola.
Dr. Schmaljohn has been one of the leaders in determining what kinds of immune responses are required for protection against viruses like Ebola, and he was part of the team that first identified antibodies capable of protecting mice and then monkeys from Ebolavirus.
Dr. Schmaljohn serves as scientific leader of the University of Maryland's partnership with Paragon Bioservices in the manufacture of an Ebolavirus (and Marburgvirus) vaccine for initial safety testing in humans.
Only human trials will provide the final answers as to which vaccines are “best” on the basis of many criteria, foremost being safety and efficacy.
In this video, Dr. Schmaljohn talks about the symptoms of Ebola virus, how it is spread, and his vaccine research.
Learn More about Dr. Schmaljohn: http://medschool.umaryland....
Media interested in interviewing Dr. Schmaljohn may contact the University of Maryland School of Medicine Office of Public Affairs at 410-706-5260
The University of Maryland School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.